Association of Central Serous Chorioretinopathy with single-nucleotide polymorphisms in Complement Factor H Gene in a Chinese population

Background: To analyze the association between central serous chorioretinopathy (CSCR) and single-nucleotide polymorphisms in the complement factor H (CFH) gene in patients of Chinese descent. Methods: 437 CSCR patients and 510 controls were enrolled from the Department of Ophthalmology, People's Hospital of Peking University. We genotyped each patient for six single-nucleotide polymorphism (SNP) markers in CFH (rs800292, rs1061170, rs3753396, rs2284664, rs1329428, and rs1065489), and assessed each SNP's associations with CSCR. We also performed a meta-analysis of CFH SNPs associations with CSCR. Results: In our Chinese population sample, two CFH SNPs—rs800292 and rs1065489—were significantly associated with CSCR. We found that rs800292 had the strongest association, and rs1065489 had the second strongest association. From a meta-analysis of all existing case-control studies on CFH SNPs and CSCR, we also found significant associations between CFH SNPs rs1329428, rs1065489, rs2284664, and rs800292, and CSCR. Conclusions: Our results show a significant association between CSCR and two SNPs in the CFH gene, rs800292 and rs1065489, in a Chinese population. These findings suggest a role for CFH in CSCR pathogenesis. Further investigation into how CFH contributes to CSCR will improve our understanding of CSCR, and of CFH as a potential therapeutic target.

[1]  M. Gazouli,et al.  PREVALENCE OF THE COMPLEMENT FACTOR H AND GSTM1 GENES POLYMORPHISMS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY , 2016, Retina.

[2]  A. D. den Hollander,et al.  Genomic Copy Number Variations of the Complement Component C4B Gene Are Associated With Chronic Central Serous Chorioretinopathy. , 2015, Investigative ophthalmology & visual science.

[3]  A. D. den Hollander,et al.  Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration. , 2015, Ophthalmology.

[4]  T. Yakut,et al.  The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels , 2014, Cutaneous and ocular toxicology.

[5]  J. Slakter,et al.  Cadherin 5 is Regulated by Corticosteroids and Associated with Central Serous Chorioretinopathy , 2014, Human mutation.

[6]  A. Negi,et al.  Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy. , 2014, Ophthalmology.

[7]  Shicheng Guo,et al.  Different hereditary contribution of the CFH gene between polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese Han people. , 2014, Investigative ophthalmology & visual science.

[8]  K Bailey Freund,et al.  PACHYCHOROID PIGMENT EPITHELIOPATHY , 2013, Retina.

[9]  G. Liew,et al.  Diagnosis and interventions for central serous chorioretinopathy: review and update , 2013, Clinical & experimental ophthalmology.

[10]  Poemen P. Chan,et al.  Risk Factors for Recurrence of Serous Macular Detachment in Untreated Patients with Central Serous Chorioretinopathy , 2011, Ophthalmic Research.

[11]  A. Lotery,et al.  Central serous chorioretinopathy: an update on pathogenesis and treatment , 2010, Eye.

[12]  L. Yannuzzi Central serous chorioretinopathy: a personal perspective. , 2010, American journal of ophthalmology.

[13]  M. Eichelbaum,et al.  Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALD-TOF mass spectrometry: reliable genotyping in different ethnic groups. , 2008, Clinical chemistry.

[14]  A. Koh,et al.  Angiographic characteristics of acute central serous chorioretinopathy in an Asian population. , 2006, Annals of the Academy of Medicine, Singapore.

[15]  E. Bouzas,et al.  Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case–control study , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[16]  M. Wolzt,et al.  Effects of adrenomedullin on ocular hemodynamic parameters in the choroid and the ophthalmic artery. , 2003, Investigative ophthalmology & visual science.

[17]  Kazuhiro Takahashi,et al.  Adrenomedullin in the eye , 2003, Regulatory Peptides.

[18]  L. Yannuzzi,et al.  Corticosteroids and central serous chorioretinopathy. , 2002, Ophthalmology.

[19]  J. Slakter,et al.  Systemic findings associated with central serous chorioretinopathy. , 1999, American journal of ophthalmology.

[20]  M. Wakakura,et al.  Corticosteroid-induced central serous chorioretinopathy. , 1997, Japanese journal of ophthalmology.

[21]  S. Carlesimo,et al.  [Masuda's Central Serous Chorioretinopathy (C.S.C.R.) and its somatic investment in Narcissism: our observations on new psychiatric nosography]. , 2014, La Clinica terapeutica.

[22]  L. Yannuzzi TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHY , 2012, Retina.

[23]  Frcs,et al.  Central Serous Chorioretinopathy , 2012 .